Pidilizumab
Pidilizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).
| Trade Name | Pidilizumab |
| Generic | Pidilizumab |
| Pidilizumab Other Names | Pidilizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pidilizumab
